2020 News Briefs - International Neuromodulation Society

Earlier News:

Deep Brain Stimulation System Receives FDA Approval for an Additional Brain Target in Parkinson's Disease

Jan. 24, 2020 - Abbott announced the FDA has approved using its deep brain stimulation system to target the globus pallidus interna to manage medication-resistant motor symptoms of Parkinson's disease. (Source: MD+DI)

Study Results Presented Concerning Spinal Cord Stimulation in Chronic Pain

Jan. 23, 2020 - Abbott announced results presented at the North American Neuromodulation Society annual meeting about two prospective studies of its spinal cord stimulation system in people in chronic pain. (Biospace)

Device Maker Announces Scientific Presentations Concerning Its Spinal Cord Stimulation System

Jan. 22, 2020 - Nevro Corp. announced there will be a series of data presentations at the North American Neuromodulation Society annual meeting this week in Las Vegas concerning the company's spinal cord stimulation system for chronic pain. (Source: PR Newswire)

Company Begins Proof-of-Concept Studies in Human Subjects

Jan. 22, 2020 - Soin Neuroscience announced the start of early stage proof-of-concept studies in human subjects for the spinal cord stimulation device that the company is developing for chronic pain. (Source: P&T Community)

Company Announces Presentation of Spinal Cord Stimulation Studies

Jan. 21, 2020 - Saluda Medical Pty Limited announced that multiple studies of its spinal cord stimulation system for treatment of chronic pain will be presented during the annual meeting of the North American Neuromodulation Society. Neurology Advisor also published a summary of recent findings. (Source: PR Newswire)

Three-month Results Released from Randomized Controlled Trial Comparing Spinal Cord Stimulation Modes

Jan. 21, 2020 - Medtronic plc announced three-month results from a randomized controlled trial of differential target multiplexed spinal cord stimulation (SCS) compared to conventional SCS, adding that the results will be presented at the annual meeting of the North American Neuromodulation Society. (Source: Globe Newswire)

Case Series Published Concerning Peripheral Nerve Stimulation in Low Back Pain

Jan. 21, 2020 - SBR Therapeutics announced publication of a prospective case series concerning its peripheral nerve stimulation system in the treatment of low back pain. (Source: NeuroNews)

Research Center Formed by Universities in Australia and China

Jan. 15, 2020 - The University of Queensland in Australia and the Southern University of Science and Technology in China established a joint Centre for Neuroscience and Neural Engineering to formalize a partnership in which surgeons from Shenzhen had been trained in neuromodulation in Queensland. The collaboration will continue with research into neural protection and repair following stroke, and improved neuromodulation techniques for movement disorders and neurological conditions. (Source: University of Queensland)

Brain Study Suggests Basis of Essential Tremor and Potential Target for Neuromodulation

Jan. 15, 2020 - A study of structural differences in the brains of people with essential tremor suggests a brain-activity cause for the condition. The research could open possibilities to reduce tremor, potentially, for instance, with noninvasive types of neuromodulation using activity in that particular brain region as a guide, according to the paper's senior author. (Source: Columbia University Irving Medical Center)

Retrospective Article Considers Issues and Advances in Neurotechnology Development

January 2020 - A year-in-review column about developments in 2019 in the neurotechnology field identifies some challenges that have remained over the past decade concerning issues such as clinical trial design of control arms and obtaining reimbursement for emerging therapies. (Source: Neurotech Reports)

Column Discusses Non-Opioid Intrathecal Pain Relief

Jan. 14, 2020 - An opinion article discusses intrathecal ziconotide in the management of chronic non-cancer pain. (Source: Expert Opinion on Pharmacotherapy)

Researcher Analyzes Factors Influencing Development of Neural Interface Technologies

Jan. 8, 2020 - A viewpoint article discusses factors affecting translational research and development of neural technology, particularly, previously approved or emerging implantable devices and functional electrical stimulation systems. (Source: Neuron)

Company's Sacral Neuromodulation System Receives Marketing Clearance in Europe

Jan. 13, 2020 - Medtronic received CE mark clearance introduce its micro neurostimulator and leads for sacral neuromodulation therapy to treat overactive bladder, fecal incontinence, and non-obstrctive urinary retention. (Source: Medgadget)

CE Mark Announced for Deep Brain Stimulation System with Recording Capability

Jan. 9, 2020 - Medtronic has received CE mark approval in Europe for a deep brain stimulation system that can record brain signals. The company said the first implantations will begin next week in western Europe. (Source: Fierce Biotech)

Implantable Vagus Nerve Stimulation Generator is Subject to an FDA Recall in the United States

Dec. 23, 2019 - LivaNova is recalling its implantable vagus nerve stimulation SenTiva Generator System following reports of 14 reset errors that caused it to stop delivering therapy. Four patients required revision surgery to replace the generator. Since mitigation steps were taken July 31, the company said no additional reset errors were reported. The FDA identified the recall, initiated on Aug. 22, as Class I. Patients whose device resets, or who experience a loss of stimulation or an increase in symptoms, are advised to immediately contact a healthcare provide to determine if a replacement is needed. The recall affects 2,909 devices in the United States; the devices that failed did so within 60 days of the start of therapy, according to the FDA. (Source: MedTech Dive)

Device Company Acquires Developer of Differential Target Multiplexed Spinal Cord Stimulation

Jan. 9, 2020 - Medtronic announced it has acquired Stimgenics, a privately held company that developed differential target multiplexed spinal cord stimulation based on studies of neural-glial interactions. Three-month results of an ongoing randomized controlled trial in chronic pain are slated for presentation at the 23rd North American Neuromodulation Society annual meeting this month in Las Vegas. (Source: NeuroNews)

Neurostimulator Receives Marketing Approval in Europe for Treatment of Fecal Incontinence

Jan. 6, 2020 - BioNess announced it has received CE mark approval for its implantable tibial nerve stimulator for the treatment of fecal incontinence. (Source: Mass Device)

Television News Segment Features Clinical Trial of Neurostimulation as a Potential Treatment for Addiction

Jan. 6, 2020 - In a medical television news segment, a Pittsburgh, PA station featured the clinical trial of deep brain stimulation to the nucleus accumbens as an investigative potential therapy for treatment-resistant addiction. (Source: KDKA)

Workshop Invites Applicants to Explore Modeling and Simulation of Peripheral Neuromodulation to Regulate Organ Function

Jan. 1, 2020 - The IT'IS Foundation, with funding from the National Institutes of Health, is seeking applicants by Jan. 31 for a 5-day Ideas Lab in April to develop solutions for predictive modeling of peripheral neuromodulation to regulate organ function. (Source: SPARC Science)

Meta-Analysis Investigates Effectiveness of Placebo Vs. Spinal Cord Stimulation

Jan. 1, 2020 - A meta-analysis of spinal cord stimulation (SCS) trials introduces a potentially generalizable differentiation between placebo and sham concepts and investigates the effectiveness of SCS when compared with placebo. (Source: Pain)

Last Updated on Saturday, January 25, 2020 03:22 PM